文献速递神经头颈MR

专用3D-T2-STIR-ZOOMit序列提高多发性硬化患者前视觉通路脱髓鞘病灶检出

Dedicated 3D-T2-STIR-ZOOMit Imaging Improves Demyelinating Lesion Detection in the Anterior Visual Pathways of Patients with Multiple Sclerosis.
PubMed 文献 · AJNR Am J Neuroradiol · 2021-03-25

前瞻性研究纳入48例多发性硬化患者和19名健康对照,在3T MR上比较3D-T2-STIR-ZOOMit与2D-T2-STIR对前视觉通路脱髓鞘病灶的检出。3D-T2-STIR-ZOOMit检出病灶数(89个)超过2D-T2-STIR(43个)的两倍(OR=2.7),颅内段91.7%的病灶未被2D-T2-STIR显示,且在无既往视神经炎患者中检出优势更明显(OR=5.9)。

要点

  • 3D-T2-STIR-ZOOMit检出前视觉通路脱髓鞘病灶数为2D-T2-STIR的两倍以上(89 vs 43,OR=2.7)。
  • 颅内前视觉通路段36个病灶中33个(91.7%)仅被3D-T2-STIR-ZOOMit检出。
  • 无既往视神经炎患者中3D-T2-STIR-ZOOMit检出病灶概率增加5.9倍(OR=5.9)。

关键影像表现/征象

  • 3D-T2-STIR-ZOOMit与2D-T2-STIR的读者间一致性均强(κ分别为0.85和0.90)。
  • 3D-T2-STIR-ZOOMit扫描-再扫描组内相关系数为0.97(95% CI,0.96-0.98;P < .001),提示可重复性极好。
  • 健康对照中未检出假阳性脱髓鞘病灶。

诊断标准与关键数值

  • 3D-T2-STIR-ZOOMit检出脱髓鞘病灶89个,2D-T2-STIR检出43个(OR=2.7;95% CI,1.7-4.1;P < .001)。
  • 颅内前视觉通路段,3D-T2-STIR-ZOOMit检出的36个病灶中33个(91.7%)未被2D-T2-STIR显示。
  • 有既往视神经炎患者中,3D-T2-STIR-ZOOMit检出脱髓鞘病灶概率增加1.8倍(OR=1.8;95% CI,1.2-3.1;P = .01)。
  • 无既往视神经炎患者中,3D-T2-STIR-ZOOMit检出脱髓鞘病灶概率增加5.9倍(OR=5.9;95% CI,2.5-13.8;P < .001)。

临床应用与阅片要点

  • 作者结论认为,专用3D-T2-STIR-ZOOMit图像可改善前视觉通路多发性硬化疾病播散的检出,颅内段和无既往视神经炎患者获益更明显。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Demyelinating lesions in the anterior visual pathways represent an underestimated marker of disease dissemination in patients with MS. We prospectively investigated whether a dedicated high-resolution MR imaging technique, the 3D-T2-STIR-ZOOMit, improves demyelinating lesion detection compared with the current clinical standard sequence, the 2D-T2-STIR.

MATERIALS AND METHODS: 3T MR imaging of the anterior visual pathways (optic nerves, chiasm, and tracts) was performed using 3D-T2-STIR-ZOOMit and 2D-T2-STIR, in patients with MS and healthy controls. Two experienced neuroradiologists assessed, independently, demyelinating lesions using both sequences separately. 3D-T2-STIR-ZOOMit scan-rescan reproducibility was tested in 12 patients. The Cohen κ was used for interrater agreement, and the intraclass correlation coefficient for reproducibility. Between-sequence detection differences and the effects of location and previous acute optic neuritis were assessed using a binomial mixed-effects model.

RESULTS: Forty-eight patients with MS with (n = 19) or without (n = 29) past optic neuritis and 19 healthy controls were evaluated. Readers' agreement was strong (3D-T2-STIR-ZOOMit: 0.85; 2D-T2-STIR: 0.90). The 3D-T2-STIR-ZOOMit scan-rescan intraclass correlation coefficient was 0.97 (95% CI, 0.96-0.98; P < .001), indicating excellent reproducibility. Overall, 3D-T2-STIR-ZOOMit detected more than twice the demyelinating lesions (n = 89) than 2D-T2-STIR (n = 43) (OR = 2.7; 95% CI, 1.7-4.1; P < .001). In the intracranial anterior visual pathway segments, 33 of the 36 demyelinating lesions (91.7%) detected by 3D-T2-STIR-ZOOMit were not disclosed by 2D-T2-STIR. 3D-T2-STIR-ZOOMit increased detection of demyelinating lesion probability by 1.8-fold in patients with past optic neuritis (OR = 1.8; 95% CI, 1.2-3.1; P = .01) and 5.9-fold in patients without past optic neuritis (OR = 5.9; 95% CI, 2.5-13.8; P < .001). No false-positive demyelinating lesions were detected in healthy controls.

CONCLUSIONS: Dedicated 3D-T2-STIR-ZOOMit images improved substantially the detection of MS disease dissemination in the anterior visual pathways, particularly in the intracranial segments and in patients without past optic neuritis.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Pravatà E, Roccatagliata L, Sormani MP, et al. Dedicated 3D-T2-STIR-ZOOMit Imaging Improves Demyelinating Lesion Detection in the Anterior Visual Pathways of Patients with Multiple Sclerosis. AJNR Am J Neuroradiol. 2021. PMID: 33766824. doi:10.3174/ajnr.A7082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。